HL,
The company has clearly stated that they're working on the BLA, I'd have to guess that it's their greatest work effort at this time. The Journal is much more in the hands of Dr. Liau and other clinicians. The advancement of the FlaskWork device would also have high priority in the company, but nothing is more important than gaining regulatory approval and the BLA is the vehicle for getting that done.
Then again, who should investors believe, you, or the company.
Gary